Press Releases Novo Nordisk A/S London S.E.

Equities

0QIU

DK0062498333

Market Closed - London S.E. Other stock markets 10:55:00 2024-07-16 am EDT			5-day change	1st Jan Change
969.2 ^DKK	-1.12%		+0.87%	+38.83%

Jul. 16	Novo Nordisk's Main Owner Leads $100 Million Financing of Biotech Firm Asceneuron	DJ
Jul. 16	Novo owner backs Swiss biotech Asceneuron in $100 million round	RE

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Novo Nordisk A/S - share repurchase programme	Jul. 15	GL
CHANGES TO THE PHARMACOSMOS BOARD OF DIRECTORS	Jul. 11	AQ
Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec	Jul. 10	GL
Novo Holdings co-leads GBP90 million Series a financing for Myricx Bio to advance a novel payload class for antibody-drug conjugates	Jul. 09	AQ
Weight loss drug Zepbound outperforms Ozempic in new published study	Jul. 08	AQ
Novo Nordisk A/S - share repurchase programme	Jul. 08	GL
Novo Holdings invests in MATR Foods expansion within plant-based fungi food	Jul. 02	AQ
Novo Nordisk A/S - share repurchase programme	Jul. 01	GL
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss	Jun. 26	GL
New US fill finish facility receives $4.1 billion investment	Jun. 26	AQ
Dewpoint Therapeutics Strengthens Collaboration with Novo Nordisk to Accelerate Drug Discovery	Jun. 26	AQ
Novo Nordisk A/S : Luxembourg ( TRANSFERT%20DES%20VALEURS%20LUX%20 %20EFPIA%20 %2025JUNE2024%20(003) )	Jun. 25	PU
Novo Nordisk A/S : Serbia ( EFPIA Disclosure Serbia 2023 )	Jun. 24	PU
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline	Jun. 24	GL
Novo Nordisk A/S - share repurchase programme	Jun. 24	GL
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month	Jun. 18	AQ
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association	Jun. 18	GL
World's first weekly insulin injection coming to Canada in 2 weeks, manufacturer says	Jun. 17	AQ
Novo Nordisk A/S - share repurchase programme	Jun. 17	GL
Haemophilia drug could reduce treated bleeding episodes	Jun. 13	AQ